Fora Capital, LLC Catalent, Inc. Transaction History

Fora Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$41.39 - $81.0 $707,975 - $1.39 Million	17,105 Added 122.99%	31,013 $1.4 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $1.01 Million - $1.57 Million	13,908 New	13,908 $1.01 Million
Q4 2021 Feb 11, 2022	SELL	$119.57 - $139.07 $1.23 Million - $1.42 Million	-10,246 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $562,989 - $734,098	5,157 Added 101.34%	10,246 $1.36 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $510,630 - $588,746	5,089 New	5,089 $550 Million
Q4 2020 Feb 12, 2021	SELL	$85.88 - $105.36 $316,897 - $388,778	-3,690 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$72.74 - $92.5 $298,161 - $379,157	-4,099 Reduced 52.63%	3,690 $316 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $339,117 - $558,180	7,062 Added 971.39%	7,789 $571 Million
Q1 2020 May 15, 2020	SELL	$36.95 - $62.95 $235,556 - $401,306	-6,375 Reduced 89.76%	727 $37,000
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $334,220 - $402,257	7,102 New	7,102 $399,000

216

73.2M

477K

2.02M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.